These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 4944229)

  • 1. Prolonged renal allograft survival associated with antigen pretreatment.
    Wilson RE; Rippen A; Hayes CR; Dagher RK; Busch GJ
    Transplant Proc; 1969 Mar; 1(1):290-2. PubMed ID: 4944229
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of SD and LD matching on kidney allograft survival in unrelated mongrel dogs.
    Westbroek DL; Vriesendorp HM; van den Tweel JG; de Gruyl J; van Urk H
    Transplant Proc; 1975 Sep; 7(3):427-9. PubMed ID: 125947
    [No Abstract]   [Full Text] [Related]  

  • 3. Thoracic duct drainage as an aid for immunosuppression in human renal transplantation.
    Murray JE; Birtch A; Wilson RE
    Transplant Proc; 1972 Dec; 4(4):465 passim. PubMed ID: 4566787
    [No Abstract]   [Full Text] [Related]  

  • 4. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts.
    MacDonald AS; Alexander JL; Busch GJ; Murray JE
    Surg Forum; 1969; 20():306-7. PubMed ID: 4192215
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of immunosuppressive treatment and leukocyte antigen matching on kidney allografts in Rhesus monkeys.
    Dicke HW; Marquet RL; Heystek GA; Balner H
    Transplant Proc; 1971 Mar; 3(1):484-7. PubMed ID: 4106328
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific suppression of renal allograft rejection by treatment with antigen and antibody.
    Stuart FP; Fitch FW; Rowley DA
    Transplant Proc; 1970 Dec; 2(4):483-8. PubMed ID: 4939695
    [No Abstract]   [Full Text] [Related]  

  • 9. Homograft survival and serum-blocking factors.
    Quadracci LJ; Pierce GE; Striker GE; Tremann JA; Marchioro TL
    Transplant Proc; 1973 Mar; 5(1):649-53. PubMed ID: 4572123
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of platelet aggregation in canine renal allotransplants with serum cytotoxic antibody following treatment with azathioprine.
    Lowenhaupt RW; Nathan P; Menefee MG
    Transplant Proc; 1971 Mar; 3(1):453-6. PubMed ID: 4937917
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic enhancement of renal allografts in the rat. I. Dissociation of graft survival and antibody response.
    Lucas ZJ; Markley J; Travis M
    Fed Proc; 1970; 29(6):2041-7. PubMed ID: 4921562
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity.
    Matsukura M; Sekiguchi M; Endo S; Kurosawa T; Koishi T
    Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression and clinical organ transplantation.
    Calne RY
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):49-51. PubMed ID: 4612904
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical use of antilymphoblast serum.
    Najarian JS; Merkel FK; Moore GE; Good RA; Aust JC
    Transplant Proc; 1969 Mar; 1(1):460-2. PubMed ID: 5002662
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal transplantation between histocompatible donor-recipient pairs.
    Seigler HF; Stickel DL; Gunnells JC; McCoy R; Ward FE; Anderson EE; Amos DB
    Transplant Proc; 1972 Dec; 4(4):439-46. PubMed ID: 4264867
    [No Abstract]   [Full Text] [Related]  

  • 16. A new in vitro test evaluating anti-lymphocyte serum potency.
    Bach JF; Dardenne M; Dormont J; Antoine B
    Transplant Proc; 1969 Mar; 1(1):403-7. PubMed ID: 4944250
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppression with cyclophosphamide in dogs following cardiac transplantation.
    Caves PK; Dong E; Shumway NE
    Transplant Proc; 1973 Mar; 5(1):517-21. PubMed ID: 4121177
    [No Abstract]   [Full Text] [Related]  

  • 18. Antilymphocyte serum (ALS) as an immunosuppressive agent in transplantation of the canine larynx. I. Preparation of antilymphocyte serum.
    Mogi G; Harvey JE; Ohyama M; Ueda N; Ogura JH
    Laryngoscope; 1972 Jan; 82(1):61-73. PubMed ID: 4109440
    [No Abstract]   [Full Text] [Related]  

  • 19. Discrepancy between PHA responsiveness and quantitative estimates of T-cell numbers in human peripheral blood during chronic renal failure and immunosuppression after transplantation.
    Lopez C; Simmons RL; Touraine JL; Park BH; Kiszkiss DF; Najarian JS; Good RA
    Clin Immunol Immunopathol; 1975 May; 4(1):135-42. PubMed ID: 1092496
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous homotransplantation of heart and kidney from the same donor in bilaterally nephrectomized dogs.
    Legrain M; Gandjbakhch ; Dubois M; Wajcner G; Rottembourg J; Guilmet D
    Transplant Proc; 1969 Mar; 1(1):293-5. PubMed ID: 4944230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.